Back to search results

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

Abroad (travel likely)RecruitingPHASE1

Conditions

Lymphoma, B-Cell · Lymphoma, Non-Hodgkin (NHL) · Lymphoma, Large B-Cell, Diffuse (DLBCL) · Chronic Lymphocytic Leukemia (CLL)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • City of Hope, Duarte, California, United States

    Contact: Study coordinator (Tanya Siddiqi, MD) · tsiddiqi@coh.org · 626-218-2405
    Contact: Principal Investigator (Tanya Siddiqi, MD)

  • The David and Etta Jonas Center for Cellular Therapy, Chicago, Illinois, United States

    Contact: Study coordinator (Michael Bishop, MD) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-6149
    Contact: Principal Investigator (Michael Bishop, MD)

  • Washington University School of Medicine/Siteman Cancer Center, St Louis, Missouri, United States

    Contact: Study coordinator (Yalda Karamlou) · yalda@wustl.edu · 314-273-3776
    Contact: Principal Investigator (Zachary Crees, MD)

  • University of Nebraska Medical Center, Omaha, Nebraska, United States

    Contact: Study coordinator (Brooke Tridle, MHA) · brtridle@unmc.edu · 402-559-5101
    Contact: Principal Investigator (Matthew Lunning, D.O. F.A.C.P.)

  • University of Cincinnatti Medical Center, Cincinnati, Ohio, United States

    Contact: Study coordinator (Hani Alrefai, MBBCh, MS, PhD) · alrefahd@ucmail.uc.edu · 513-584-8438
    Contact: Principal Investigator (Zulfa Omer, MD)

  • Fred Hutch Cancer Center, Seattle, Washington, United States

    Contact: Study coordinator (Shelby Colden) · scolden2@fredhutch.org · 206-667-5134
    Contact: Principal Investigator (Ajay Gopal, MD/FACP)

  • Royal North Shore Hospital, Saint Leonards, New South Wales, Australia

    Contact: Study coordinator (Cameron Turtle, MBBS, PhD) · +61299264377
    Contact: Principal Investigator (Cameron Turtle, MBBS, PhD)

  • St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia

    Contact: Study coordinator (Joseph Nguyen-Vo) · Joseph.Nguyen@svha.org.au · +61 3 9231 3263
    Contact: Principal Investigator (Matthew Ku, MD)
Study leads

  • Jacob Garcia, MD

    Study Director

    Umoja Biopharma

View source on ClinicalTrials.gov(opens in a new tab)